MVC’s WHO-Partnered Vaccine a First for Taiwan
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its…
EY is a global leader in professional services, employing 167,000 people in 150 countries and 728 offices around the globe. Their global revenues amounted to US$24.4 billion in financial year 2012. Apart from auditing services, EY also provides advisory services including tax advisory, transaction advisory, internal control, risk management, information technology security, performance improvement and corporate governance, etc. They are recognized for “delivering value” to their clients in different service areas. In 2012, they provided audit, risk management, tax and other advisory services to 80 percent and 63 percent of Fortune Global 500 and Forbes Global 2000 companies, respectively. Their strategy is to use their global professional talent and knowledge to assist their clients to tackle challenges in an ever-changing market environment.
EY Taiwan was established as the first partnership accounting firm in Taiwan, and is an official member of EY. They employ 1,200 professionals across Taiwan by creating the right team in the right place, and provide clients with multi-disciplinary assurance, business advisory, tax and transaction advisory services. Their main office is located in Taipei, with five branch offices in Chungli, Hsinchu, Taichung, Tainan, and Kaohsiung. They have joined EY in China and Hong Kong in forming the Greater China Area to provide clients with comprehensive and efficient services by leveraging their knowledge base and integrated network.
Contact details
Assurance
Based on legitimate professional standards, their assurance, financial report audit, and other value added services assist companies to improve effectiveness and quality.
Assurance Services Leader: Kim Chang / +886-2-2757-8888 #2317
Tax
They help companies navigate the latest tax policies, provide tax assessment and diagnosis, and address potential tax risks.
Tax Services Leader: Heidi Liu / 886-2-2757-8888 #2705
Transactions
They assist clients to evaluate, negotiate, structure, and succeed in transactions by seizing market opportunities to sustain advantageous position and boost growth.
Transaction Advisory Services Managing Director: Jonathan Hsin / +886-2-2757-8888 #1527
Advisory
When major issues strike, their approach helps organizations reduce risks, improve performance, overcome the internal and external challenges, and maximize profits.
Advisory Services Managing Director: Tony Chang / +886-2-2757-8888 #1563
Entrepreneurship
They celebrate entrepreneurs who lead the companies to embed innovation and embrace growth honoring their visions, leaderships, and extraordinary achievements. They present Taiwan entrepreneurship to the world through EY’s global network.
Ernst & Young Foundation / +886-2-2757-8888
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its…
In an important milestone for Taiwan’s biotech industry, Diamond Biofund – one of the territory’s most well-established venture capital (VC) funds – became the first such firm to list on…
The latest pharma news from Taiwan, including Gongwin-KY’s lung cancer drug approval in China, Anxo Pharmaceutical/Genovior Biotech alliance, Taiwan’s Industrial Technology Research Institute (ITRI) and Metagone Biotech’s glaucoma and macular…
The latest healthcare and pharma news from Taiwan, including the CDMO Bora Pharmaceutical’s acquisition of Eden Biologics assets, the FDA fast track granted to the Taiwanese biomedical group United Biomedical’s…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what MVC’s competitive advantages are. At MVC we have…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their technology’s unique characteristics, how it differs from sequencing technologies in terms of cost and speed,…
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody technologies, his ambitious internationalization plans, and comments on the vital role that companies like Leadgene have…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s rapid and coordinated response to the COVID-19 crisis and also explains how Quark Biosciences’ diagnostics and precision…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours. Here, three country managers for…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global…
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market, rising medical needs in Asia are helping foster more regionally-focused strategies. …
All country managers of multinational pharma companies need to strike the balance between having a global outlook and adapting to local culture. For BoonHuey Ee, general manager of Merck Biopharma…
See our Cookie Privacy Policy Here